fashion -WSS

fashion

author：comprehensive 2025-10-01 02:13:42 - browse：8625

Amedisys -- Hospital coverage from STAT — Option Care Health is buying Amedisys, creating a national company that specializes in almost all types of home care. Wikimedia Commons

Option Care Health is buying Amedisys in an all-stock merger valued at $3.6 billion, creating a national company that specializes in almost all types of home care that can be provided from cradle to grave.

Health insurance companies, providers, and patients have pushed for more care to be handled at home instead of a hospital or post-acute facility, under the idea that quality home care saves money and is what patients want. Option Care’s deal for Amedisys marks another instance of this push, and comes just a few months after UnitedHealth Group closed on its $5.4 billion acquisition of LHC Group.

But Wall Street was not receptive to the deal, driving down Option Care’s stock by more than 25% on Thursday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： FDA panel issues narrow recommendation for Covid vaccine booster doses

entertainment

WSS

Drastic changes should bring profitability, startup health insurers say

'Hero' Louisville officer shot in head at mass shooting discharged over 3 months later

Stoke drug shows lower activity against childhood epilepsy

CDC: Cases of alpha

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Behind warning on Apellis’s eye drug lies a conflict of interest

focus

fashion

leisure time

The cancer drug shortage isn’t new — and neither are the solutions

Why failed clinical trials don’t always spell doom for a new drug

How to save PrEP access — and even expand it

Behind warning on Apellis’s eye drug lies a conflict of interest

Cancer drug shortages should be causing more outrage

Anavex keeps shifting the goalposts in its clinical trials

Psychedelics group wrestles with new pharma identity

The Jan. 6 committee previously recommended Trump be criminally charged. Here's why

Heart attack and stroke risk calculators need revising

Behind warning on Apellis’s eye drug lies a conflict of interest

entertainment

Man killed during FBI raid in connection with threats against Biden, other officials

Marc Tessier

A biotech analyst on neuroscience, placebo effect, not over

Public health communication lessons from Covid

Trump lawyers meet with special counsel in Jan. 6 case as potential indictment looms

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Wikipedia

hotspot

entertainment

focus